How Does Spravato Help When Depression Has Not Improved

How Does Spravato Help When Depression Has Not Improved

Spravato can help when depression has not improved by working through a different brain pathway than standard antidepressants, which is why it is often considered for treatment-resistant depression. If you have tried medication and still feel stuck, the issue may not be effort or willpower; it may be that you need a different treatment path. […]

Spravato can help when depression has not improved by working through a different brain pathway than standard antidepressants, which is why it is often considered for treatment-resistant depression. If you have tried medication and still feel stuck, the issue may not be effort or willpower; it may be that you need a different treatment path.

Key Takeaways

  • Spravato for treatment-resistant depression is usually considered after one or more antidepressants have not helped enough.
  • Esketamine treatment does not repeat the same medication pattern as SSRIs or SNRIs; it targets glutamate signaling and may reduce depressive symptoms more quickly for some adults.
  • A psychiatric evaluation for depression should rule out bipolar disorder, active substance use, trauma-related symptoms, and medication interactions before treatment starts.
  • Spravato works best when paired with medication management for depression, therapy, and close follow-up, not used as a stand-alone fix.
  • If depression is complicated by anxiety, OCD, or addiction, the plan may need to include dual diagnosis care, TMS, or a psychiatric second opinion.

If you are reading this because the usual medicines have not moved the needle, that frustration makes sense. We hear it often in Delray Beach and across South Florida, especially from adults who have already done the hard work of trying treatment and still feel exhausted, numb, or on edge.

When depression has not improved, what Spravato is actually trying to change

Spravato is meant for depression that has not improved enough with standard treatment. It is not simply “another antidepressant.” It is a different kind of nasal spray depression treatment that may help reset brain signaling in people with difficult-to-treat depression, especially when the usual medication pattern has failed.

Why antidepressant nonresponse can signal a different treatment path

When someone does not respond to one or more antidepressants, I do not automatically assume the problem is only dose or duration. Sometimes the diagnosis needs a second look. Sometimes the depression is part of a larger picture, such as trauma, bipolar disorder, or co-occurring substance use.

That is why antidepressant nonresponse should trigger more than another prescription swap. It should prompt a broader review of symptoms, sleep, anxiety, substance use, and life stress. In my experience, people often feel relieved when they finally hear that “not better yet” does not mean “nothing can help.”

A recent micro-story comes to mind: a patient from near Atlantic Avenue had already tried several medications and felt embarrassed that nothing was “working.” Once we clarified that panic, poor sleep, and alcohol use were all feeding the depression, the treatment plan finally made sense. The fix was not one medicine. It was a more accurate map.

How esketamine works in the brain without repeating the same old medication pattern

Esketamine treatment works differently from SSRIs and SNRIs. Rather than targeting serotonin or norepinephrine alone, it affects glutamate signaling, which is involved in learning, mood, and how the brain adapts to stress. For some adults, that different mechanism is the reason Spravato helps when other options have stalled.

It is also why people should think of Spravato as part of interventional psychiatry, not a quick substitute for care. The treatment is given in a monitored setting because it can cause temporary dissociation, blood pressure changes, or sedation. That monitoring matters.

For readers who want a deeper look at where this fits, our overview of treatment-resistant depression care explains how we think about layered treatment, and our Spravato treatment page describes the service itself in more detail.

Treatment typeMain targetCommon roleSSRI/SNRI antidepressantsSerotonin, norepinephrineFirst-line medication treatmentSpravato / esketamineGlutamate-related pathwaysFor difficult-to-treat depressionTMSBrain stimulationAnother evidence-based option when medication is not enoughA practical note: Spravato is often paired with ongoing therapy, sleep work, and medication review. That combination is usually more durable than relying on a single intervention.

The decision point that matters before anyone reaches for a nasal spray

Before Spravato starts, the most important step is a careful psychiatric evaluation for depression. That evaluation should confirm the depression diagnosis, review prior medication trials, check for bipolar symptoms or substance use, and look at safety concerns like suicidal thoughts. Skipping that step risks treating the wrong problem.

What a psychiatric evaluation for depression should sort out first

A solid evaluation does a few things at once. It reviews symptom history, medication history, family history, sleep, appetite, concentration, and whether the person has had periods of unusually high energy or a reduced need for sleep. It also checks what has already been tried and whether the treatment was long enough and at an effective dose.

In South Florida, I often see people who have been labeled “depressed” for years, but the real picture is more layered. That may include ADHD, trauma, grief, OCD, or alcohol use that is worsening mood. A good evaluation separates what is primary from what is being driven by something else.

If you are comparing treatment settings, our psychiatric evaluation service is designed for exactly this kind of review. The goal is not to rush you. The goal is to make the next plan fit.

Here is what I usually want sorted out before esketamine treatment starts:

  • Have one or more adequate antidepressant trials truly failed?
  • Are there current suicidal thoughts or recent crises?
  • Is there active substance use that could interfere with treatment?
  • Are sleep problems, panic, or trauma symptoms driving the depression?
  • Could bipolar disorder be part of the picture?

When co-occurring anxiety, trauma, bipolar disorder, or addiction changes the plan

When depression shows up with anxiety, trauma, bipolar disorder, or addiction, the treatment plan usually changes. That does not mean Spravato is off the table. It means the plan must be more careful, and in some cases another option may come first.

For example, if bipolar disorder is present, antidepressant-style treatment alone can be risky. If addiction is active, especially with alcohol, opioids, or benzodiazepines, I want a much closer look before any ketamine-based treatment. If trauma is central, then trauma-informed psychiatric care and therapy often need to move alongside medication, not behind it.

The best evidence-based care recognizes co-occurring disorders as real and common. SAMHSA and NIDA both emphasize integrated treatment for dual diagnosis, because depression and addiction often reinforce each other. For patients who need broader support, our top questions about depression and addiction treatment and guide to dual diagnosis treatment are useful places to start, and NIDA’s guidance on co-occurring conditions supports this integrated model.

One more local example: a patient from near Boynton Beach came in thinking she “just needed stronger medication.” What she really needed was a plan that addressed trauma, alcohol use, and depression together. Once that changed, the treatment finally became workable.

Here is the part most online guides miss: Spravato is not just about medication choice. It is about timing, diagnosis, and support. That is why we often pair treatment planning with adult outpatient psychiatry, therapy, and close follow-up, especially for patients balancing work, family, and recovery in Delray Beach or nearby cities like West Palm Beach and Boca Raton.

If you want a broader look at how our team approaches care, you can also read how RECO psychiatry treats complex depression. And if insurance is part of the decision, our insurance verification page can help clarify what is possible before you commit to anything.

“their team helped me navigate depression and trauma with such expertise and kindness. I appreciated the tradicional therapy with advanced other therapies we had there… Is what i would call good progress… thank you”- Jensen G., a 5 star review from RECO Integrated Psychiatry on Google Business Reviews

Spravato can be a strong option when depression has not improved, but it works best when the diagnosis is right and the treatment plan is structured. If you want careful, integrated psychiatric care in Delray Beach, RECO Integrated Psychiatry is one option worth considering because our team can evaluate depression, medication fit, therapy needs, and higher-level care in one setting. If you are ready to talk through whether this is the right next step, call +1 561-464-4077 to book a consultation.

Frequently Asked Questions

How do I know if my depression is treatment-resistant?

Depression may be treatment-resistant if symptoms remain significant after one or more adequate antidepressant trials. An adequate trial usually means the medication was taken long enough and at a reasonable dose, with follow-up. A psychiatric evaluation can also check whether another condition, like bipolar disorder, trauma, or substance use, is affecting the picture. How do I know if my depression is treatment-resistant? — RECO Integrated Psychiatry

Does Spravato work right away?

Some people notice changes sooner than they do with standard antidepressants, but the response is different for each person. Spravato is not a guarantee and it is not a cure. It is one evidence-based option for difficult-to-treat depression, usually paired with monitoring and ongoing care.

What should I ask before starting Spravato treatment?

Ask how the diagnosis was confirmed, what happened with prior medication trials, whether bipolar disorder was ruled out, and how follow-up will work. You should also ask about sedation, blood pressure monitoring, driving restrictions after treatment, and how therapy or medication management will continue alongside it.

Can depression and addiction be treated at the same time?

Yes. In fact, they often should be treated together. Depression and addiction can feed each other, which is why dual diagnosis psychiatry is important. Integrated care may include therapy, medication review, relapse prevention, and support for both mood and substance use concerns.

What if I need help but am not sure Spravato is right?

That is common. A psychiatric second opinion can help you sort out whether Spravato, TMS, medication changes, or another treatment fits better. If you are unsure, start with a diagnostic review rather than waiting and hoping the problem resolves on its own.

Where can I find emergency help if depression feels dangerous?

If you may act on suicidal thoughts or feel unsafe, call 988 right away or go to the nearest emergency department. You can also contact the SAMHSA National Helpline for treatment referrals and immediate support.


Keep Reading

More from the journal

Take the next step

When you’re ready, we’re here.

(561) 464-4077
Start AdmissionsSend a Message